Search Menu

Archives

HSV

HSV – Herpes Simplex Virus. HSV-1 is the virus mainly associated with cold sores on your lips or faces. HSV-2 is the virus mainly associated with genital herpes. The viruses are very similar.

boosted-PI

boosted-PI – a protease inhibitor taken with an additional dose of ritonavir. The ritonavir boost levels of the protease inhibitor by either increasing the initial drugs levels or reducing how quickly or reducing how quickly it is removed by your …

antiretrovirals

antiretrovirals – the common name for any HIV drugs. HIV is a retrovirus, so drugs to fight HIV are called antiretrovirals. Also abbreviated to ARVs.

Abstract

abstract – in research, a short summary of a study (usually about 350 words)

icterus

icterus – medical term for jaundice (yellowing skin)

AIDS 2010: non-technical summary from IAS conference in Vienna

This supplement to the September/October issue of HIV Treatment Bulletin is a non-technical summary from the recent 18th World AIDS Conference held in Vienna. The electronic versions (online and PDF file) include hyperlinks to the original studies on the conference …

Introduction to combination therapy (Estonian)

Please click title link for the download page.

START trial if you are a long-term slow progressor

START LTNP leaflet PDF file (60 Kb) The START study – if you are a LTSP… Is your CD4 above 500 without treatment? Are you a long-term slow progressor? This leaflet explains why HIV treatment might be a good idea …

START trial if you were recently diagnosed

START newly diagnosed leaflet PDF (60 Kb) The START study – if you have been recently diagnosed… Do you have a CD4 count over 500? Were you recently diagnosed? Are you not yet on HIV treatment? This leaflet explains why …

IAS report: Caprisa 004 tenofovir microbicide trial – all in the details

We lead our coverage from the IAS conference in Vienna with an analysis of  the Caprisa 004 trial. In terms of conference headlines, the biggest news came from the results of a prevention study called Caprisa 004. This study reported …

HTB July/August 2010 now online

In this issue we lead with reports from the 18th International AIDS Conference, which took place in Vienna in July. As we explain in our introduction, access to treatment, to which there are many barriers – including unjust legislation, donor …

febrile

febrile – medical word relating to fever

dyspepsia

dyspepsia – a range of symptoms related to digestion problems that can include pain, nausea, heart burn. vomiting and pain in the stomach or upper intestine.

specificity (of a test)

specificity – when referring to the accuracy of a test result, specificity refers to the proportion of people who do not have an illness or disease who have a negative test result. If a test has low specificity, the concern …

Sensitivity – of a test or drug

sensitivity – when referring to the accuracy of a test result, sensitivity refers to the proportion of people with an illness or disease who have a positive test result. If a test has low sensitivity, then false-negative results are the …

Introduction to Combination Therapy – July 2010 edition

Updated guide – HIV treatment explained using everyday language.

Pipeline report 2010

Pipeline report 2010: launched at IAS conference in Vienna HIV, tuberculosis, and viral hepatitis: drugs, diagnostics, vaccines, immune-based therapies, and preventive technologies in development This year i-Base is partnering with Treatment Action Group (TAG) to produce a pipeline report on …

somnolence

somnolence – feeling sleepy or drowsy, especially during the day.

Article on START study in HIV Treatment Update (NAM/aidsmap) – June 2010

START… and why the time is now? Simon Collins of HIV i-Base looks at an important and exciting new study, which needs your help. The START study (Strategic Timing of Antiretroviral Therapy) is exploring when to start treatment and many …

Article on START study in BASELINE magazine – June 2010

The START study ­– if your CD4 is over 500 off-treatment… Simon Collins, HIV i-Base An important new study is enrolling in the UK and needs your help. The START study (Strategic Timing of AntiRetroviral Therapy) looks at when to …

Post navigation